Chronic dacryosialadenitis in HTLV I associated myelopathy
Author
dc.contributor.author
Cartier Rovirosa, Luis
Author
dc.contributor.author
Castilio,
Author
dc.contributor.author
Cea,
Author
dc.contributor.author
Villagra,
Admission date
dc.date.accessioned
2019-01-29T15:32:05Z
Available date
dc.date.available
2019-01-29T15:32:05Z
Publication date
dc.date.issued
1995
Cita de ítem
dc.identifier.citation
Journal of Neurology Neurosurgery and Psychiatry, Volumen 58, Issue 2, 2018, Pages 244-246
Identifier
dc.identifier.issn
00223050
Identifier
dc.identifier.other
10.1136/jnnp.58.2.244
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161557
Abstract
dc.description.abstract
A prospective study was carried out on 48 patients with HTLV I associated myelopathy/tropical spastic paraparesis (HAM/TSP) to assess the association between this entity and Sjogren's syndrome. Fourteen patients (29.1%) had chronic dacryosialadenitis confirmed by a positive Schirmer's test and salivary gland biopsy. None of these patients had evidence of collagen disease and tests for Ro, La, and rheumatoid factor were negative except in one case. Therefore, the dacryosialadenitis could not be classified as either primary or secondary Sjogren's syndrome. Ten of the 14 patients (71.4%) had other systems (haematological, articular, dermatological, or respiratory) involved apart from the neurological and exocrine gland pathology. The findings suggest that the dacryosialadenitis associated with HTLV I is a disease of viral origin distinct from Sjogren's syndrome.